Actively Recruiting
Heart Failure With Preserved Ejection Fraction in Patients With Сhronic Obstructive Pulmonary Disease: Clinical Course and Prognosis
Led by National Medical Research Center for Therapy and Preventive Medicine · Updated on 2026-02-10
200
Participants Needed
2
Research Sites
52 weeks
Total Duration
On this page
Sponsors
N
National Medical Research Center for Therapy and Preventive Medicine
Lead Sponsor
K
Kazan State Medical University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Study aim is comparison of heart failire with preserved ejection fraction (HFpEF) detection rate in patients with Сhronic Obstructive Pulmonary Disease (COPD) and the clinical course and prognosis in patients with COPD depending on HFpEF presence.
CONDITIONS
Official Title
Heart Failure With Preserved Ejection Fraction in Patients With Сhronic Obstructive Pulmonary Disease: Clinical Course and Prognosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Verified diagnosis of COPD
- Patients hospitalized with COPD
- Citizenship of the Russian Federation
- Patients aged 50 to 70 years
- Patient consent to participate in the study
You will not qualify if you...
- Lack of Russian Federation citizenship
- Patient's refusal to participate in the study
- Any chronic diseases, other than COPD, that affect the prognosis, in the acute and/or decompensated stage
- Mental disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Kazan State Medical University
Kazan', Russia
Actively Recruiting
2
National Medical Research Center for Therapy and Preventive Medicine
Moscow, Russia
Actively Recruiting
Research Team
Y
Yury S Timofeev, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here